Longevity Health Holdings, Inc. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
Longevity Health Holdings, Inc. (XAGE) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of -$393.34 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2026-05-15
- Longevity Health Holdings, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2026-03-31 was -$393.34K, a 164.18% decline year-over-year.
- Longevity Health Holdings, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2025-03-31 was $612.91K.
- Longevity Health Holdings, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2024-03-31 was -$2.02M.
- Longevity Health Holdings, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2023-03-31 was -$100.96K.
- Longevity Health Holdings, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2025 was $549.60K.
- Longevity Health Holdings, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2024 was -$2.76M, a 198.96% decline from fiscal 2023.
- Longevity Health Holdings, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2023 was $2.78M, a 2304.68% increase from fiscal 2022.
- Longevity Health Holdings, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2022 was $115.79K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 5 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 8 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 11 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | -$393.34K 10-Q · filed 2026-05-15 | ||||||||||
| 2025-12-31 | $549.60K 10-K · filed 2026-03-31 | ||||||||||
| 2025-09-30 | $952.09K 10-Q · filed 2025-11-14 | ||||||||||
| 2025-06-30 | $1.39M 10-Q · filed 2025-08-14 | ||||||||||
| 2025-03-31 | $612.91K 10-Q · filed 2026-05-15 | ||||||||||
| 2024-12-31 | -$2.76M 10-K · filed 2026-03-31 | ||||||||||
| 2024-09-30 | -$1.78M 10-Q · filed 2025-11-14 | ||||||||||
| 2024-06-30 | -$714.19K 10-Q · filed 2025-08-14 | ||||||||||
| 2024-03-31 | -$2.02M 10-Q · filed 2025-05-15 | ||||||||||
| 2023-12-31 | $2.78M 10-K/A · filed 2025-06-17 | ||||||||||
| 2023-09-30 | $6.97M 10-Q · filed 2024-11-14 | $7.84M 10-Q · filed 2023-11-15 | |||||||||
| 2023-06-30 | -$112.23K 10-Q · filed 2024-08-14 | -$177.42K 10-Q · filed 2023-08-14 | |||||||||
| 2023-03-31 | -$100.96K 10-Q · filed 2024-05-15 | -$171.53K 10-Q · filed 2023-05-15 | |||||||||
| 2022-12-31 | $115.79K 10-K · filed 2024-04-01 | -$586.53K 10-K · filed 2023-03-17 | |||||||||
| 2022-09-30 | -$1.49K 10-Q · filed 2023-11-15 | ||||||||||
| 2022-06-30 | -$222.69K 10-Q · filed 2023-08-14 | ||||||||||
| 2022-03-31 | -$179.46K 10-Q · filed 2023-05-15 | ||||||||||
| 2021-12-31 | $774.19K 10-K · filed 2023-03-17 | ||||||||||
| 2021-09-30 | $849.65K 10-Q/A · filed 2022-09-13 | ||||||||||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STEPAN CO (SCL) | United States | $1.451B | -477.05 |
| CHURCH & DWIGHT CO INC /DE/ (CHD) | United States | $22.622B | 30.81 |
| ECOLAB INC. (ECL) | United States | $77.183B | 36.58 |
| PROCTER & GAMBLE Co (PG) | United States | $338.763B | 21.26 |